This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Medco Deal Fuels Health Care's Hot Streak

BOSTON ( TheStreet) -- The offer by Express Scripts (ESRX - Get Report) to acquire Medco (MHS) is drawing attention to health care as investors look for opportunities in 2011's hot sector.

Health care is the best-performing industry group of the 10 majors in the S&P 500 this year, with its 46 components delivering a median gain of 13%. Top performers include Biogen Idec (BIIB - Get Report), Intuitive Surgical (ISRG - Get Report) and Humana (HUM - Get Report).

Thursday's deal may make Express Scripts the largest pharmacy benefits manager in the U.S., controlling 30% of the market. CVS Caremark (CVS) would be the odd man out, in second place for market share.

The $71.36 per-share offer, denominated in both cash and stock, represents a 28% premium to Medco's closing share price, as of yesterday. The premium is warranted, given that the new company would have tremendous synergies, from a cost and growth perspective. Therefore, it is likely to be scrutinized by regulators. The acquisition will help Express Scripts compete in the low-margin business of distributing drugs for insurance companies and employers. Express Scripts posted a first-quarter net margin of 2.9% and Medco achieved a spread of around 2%.

The catalyst for the deal: Medco has suffered major contract losses as of late, including a partnership with UnitedHealth (UNH), accounting for as much as $11 billion of sales. The company also lost contracts in March, pressuring the management team to explore strategic options to unlock value for shareholders.

The deal announcement marks the second largest of the year, after AT&T (T) declared its intention to buy T-Mobile USA for $39 billion. Analysts are offering positive reviews, so far, while stressing that anti-trust regulators will thoroughly weight the benefits and costs of the deal for consumers, the industry and shareholders. Health care has been hot in 2011.

Express Scripts shares have rallied 24% in the past 12 months and Medco's have appreciated 21%. Equity researcher Leerink Swann expects the deal to increase Express Scripts' earnings, citing $1 billion of synergies. Leerink Swann views the deal as "a significant positive for both companies." Bank of America went further than Leerink Swann by saying that "estimated synergies of $1 billion seem conservative." The pharmacy benefits business depends on scale and bargaining power, which will be vastly amplified by the deal.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
MHS $70.30 0.00%
ABT $46.78 0.00%
BAC $15.31 0.00%
BIIB $429.87 0.00%
ESRX $82.38 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs